STOCK TITAN

Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vor Bio (Nasdaq: VOR) will participate in two upcoming investor conferences in August 2022. The first is the BTIG Biotechnology Conference 2022 where a pre-recorded fireside chat will be available starting August 8 at 9:00 AM ET. The second event is the 2022 Wedbush PacGrow Healthcare Conference, featuring a panel discussion titled A View to a Kill(er Cell) - Part 1 on August 10 at 1:10 PM ET. Live webcasts and archived replays will be accessible on their investor website, showcasing Vor Bio's commitment to advancing treatments for blood cancers.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

BTIG Biotechnology Conference 2022 (Hybrid)
Fireside Chat: A pre-recorded fireside chat will be available via the conference website starting August 8, 2022 at 9:00 AM ET.

2022 Wedbush PacGrow Healthcare Conference (Virtual)
Panel: A View to a Kill(er Cell) - Part 1
Panel date/time: Wednesday, August 10, 2022, 1:10pm ET

A live webcast and archived replay of the panel will be available on the investors section of www.vorbio.com.

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


FAQ

What is Vor Bio's participation in the BTIG Biotechnology Conference 2022?

Vor Bio will have a pre-recorded fireside chat available starting August 8, 2022, at 9:00 AM ET.

When is Vor Bio's panel discussion at the 2022 Wedbush PacGrow Healthcare Conference?

The panel discussion titled 'A View to a Kill(er Cell) - Part 1' is scheduled for August 10, 2022, at 1:10 PM ET.

How can I access Vor Bio's conference webcasts?

Live webcasts and archived replays of Vor Bio's conference appearances will be available on their investor section of the website.

What is the focus of Vor Bio as a company?

Vor Bio aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells for targeted therapies post-transplant.

Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

VOR Latest News

VOR Stock Data

54.58M
67.89M
1.17%
81.25%
2.49%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE